Central Nervous System Involvement of Epstein Barr Virus Associated Lymphoproliferative Disorder in a Child with Acute Lymphoblastic Leukemia: Successful Treatment with Rituximab and Interferon-Alpha

Central nervous system (CNS) involvement of Epstein-Barr virus (EBV)-associated lymphoproliferative disease is a rare and serious complication in children with leukemia. Although rituximab therapy seems to be promising in these cases, persistent hypogammaglobulinemia may appear after treatment due t...

Full description

Bibliographic Details
Published in:	Turkish Journal of Hematology
Main Authors:	Berna Atabay, Meral Türker, Can Öztürk, Sümer Sütçüoğlu, Haldun Öniz, Esra Arun Özer
Format:	Article
Language:	English
Published:	Turkish Society of Hematology 2013-03-01
Subjects:	epstein-barr virus lymphoproliferative disorder rituximab children leukemia
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-43926

Similar Items

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
by: Takeo Mukai, et al.
Published: (2023-09-01)

Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
by: Xi Yang, et al.
Published: (2015-10-01)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
by: Yumiko Ban, et al.
Published: (2020-07-01)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
by: Junhong Ai, et al.
Published: (2018-10-01)

Epstein–Barr Virus Detection in Lymphoproliferative Disorders: Epidemiological Characterization in Western Mexico
by: Karel Cesar Licona-Lasteros, et al.
Published: (2025-08-01)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
by: Sylvain Latour, et al.
Published: (2018-06-01)

Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
by: Ruben Fernandez, et al.
Published: (2014-02-01)

Epstein-Barr virus-related lymphoproliferative disorders of the skin
by: Gerardo Ferrara, et al.
Published: (2024-05-01)

EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)

A case of coexistence of hydroa vacciniforme-like lymphoproliferative disorder and Epstein-Barr virus pneumonia
by: Wei Zhang, MD, PhD, et al.
Published: (2025-09-01)

Chylous abdomen with Epstein-Barr virus-associated T Lymphoproliferative diseases in children: A case report
by: Jie Liu, et al.
Published: (2023-11-01)

Successful low‐dose chemotherapy for refractory Epstein‐Barr virus—related post‐transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott‐Aldrich syndrome
by: Bixin Xi, et al.
Published: (2021-05-01)

Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient
by: Juan Hu, et al.
Published: (2023-09-01)

Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
by: Sabri SH., et al.
Published: (2005-09-01)

Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
by: SH Sabri, et al.
Published: (2005-09-01)

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder
by: Süreyya Yiğit Kaya, et al.
Published: (2023-01-01)

Actualización en procesos linfoproliferativos cutáneos relacionados con el virus de Epstein Barr: revisión sistemática
by: S. García-González, et al.
Published: (2025-04-01)

Lymphoproliferative Syndrome in Pediatrist and Infectiologist Practice
by: E. N. Simovanyan, et al.
Published: (2010-06-01)

Comparative Study on Epstein-Barr Virus-Positive Mucocutaneous Ulcer and Methotrexate-Associated Lymphoproliferative Disorders Developed in the Oral Mucosa: A Case Series of 10 Patients and Literature Review
by: Kyoichi Obata, et al.
Published: (2021-07-01)

Spontaneous regression of chronic epstein –Barr virus infection-related lymphoproliferative disease
by: Bharti Kumari, et al.
Published: (2021-01-01)

Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
by: Takeshi Namiki, et al.
Published: (2018-05-01)

Post-transplant Epstein–Barr virus-related lymphoproliferative disorder: A case report and review of literature
by: Vasu Babu Goli, et al.
Published: (2019-01-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Plasma Epstein-Barr Virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr Virus infection
by: Chunxiang Ma, et al.
Published: (2025-01-01)

Epstein-Barr virus and skin
by: Martin Sangueza-Acosta, et al.
Published: (2018-12-01)

First Report of an SH2D1A Mutation Associated with X-Linked Lymphoproliferative Disease in Turkey
by: Selman Kesici, et al.
Published: (2018-08-01)

Post-transplant lymphoproliferative disease
by: Nieto-Ríos, John Fredy, et al.
Published: (2016-07-01)

Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge
by: Aleksandra Szczawińska-Popłonyk, et al.
Published: (2021-12-01)

Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada
by: Claire Ratiu, et al.
Published: (2024-05-01)

Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
by: Masataka Ishimura, et al.
Published: (2019-05-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)

Histopathological characteristics of Epstein-Barr virus (EBV)–associated encephalitis and colitis in chronic active EBV infection
by: Betty A Kasimo, et al.
Published: (2025-05-01)

Clinicopathological findings, prognosis, and Epstein–Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders
by: Shoichi Kimura, et al.
Published: (2022-12-01)

A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab
by: Bellia M, et al.
Published: (2024-10-01)

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
by: Rebecca E. Schultze-Florey, et al.
Published: (2018-06-01)

Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges
by: Daisuke Sato, et al.
Published: (2023-06-01)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
by: Masaaki Hotta, et al.
Published: (2018-05-01)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
by: Polina Shindiapina, et al.
Published: (2020-09-01)

Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
by: Hui Zhang, et al.
Published: (2022-10-01)

Epstein–Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report
by: Yaxian Ma, et al.
Published: (2023-07-01)